Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy China Pharma stock

Learn how to easily invest in China Pharma stock.

China Pharma Holdings Inc
- $0.0023 ( - 1.05%)

China Pharma Holdings Inc is a drug manufacturers-specialty & generic business based in the US. China Pharma shares (CPHI) are listed on the NYSE MKT and all prices are listed in US Dollars. China Pharma employs 236 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in China Pharma

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – CPHI – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.

China Pharma stock price (NYSE MKT: CPHI)

Use our graph to track the performance of CPHI stocks over time.

China Pharma shares at a glance

Information last updated 2022-07-03.
Latest market close$0.22
52-week range$0.20 - $0.97
50-day moving average $0.25
200-day moving average $0.42
Wall St. target price$3.00
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-0.08

Buy China Pharma shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 5 of 5
Name Product Asset types Stock trade fee Minimum deposit Signup bonus
Finder Award
Stocks, ETFs, Cryptocurrency
when you sign up and deposit $100
Trade stocks in the app or online with $0 commissions. Not available in NY, NV, MN, or TN.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.
SoFi Invest
Stocks, ETFs, Cryptocurrency
$10 - $100
when you open an account and place a first crypto trade of $50 - $5,000+
A free way to invest in most equities.
Stocks, Options, ETFs, Cryptocurrency
$200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.
JPMorgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$125 - $625
when you open and fund an account with $25,000 - $250,000+
Axos Bank Self Directed Investing
when you open an account and deposit at least $1500.

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy China Pharma stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

China Pharma price performance over time

Historical closes compared with the close of $0.22 from 2022-07-01

1 week (2022-06-28) 0.22
1 month (2022-06-03) -8.33%
3 months (2022-04-05) -43.59%
6 months (2022-01-05) -48.84%
1 year (2021-07-02) -69.01%
2 years (2020-07-02) -63.52%
3 years (2019-07-05) 0.3078
5 years (2017-07-05) 0.2335

Is China Pharma stock undervalued or overvalued?

Valuing China Pharma stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of China Pharma's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

China Pharma's EBITDA

China Pharma's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $25,430.

The EBITDA is a measure of a China Pharma's overall financial performance and is widely used to measure a its profitability.

China Pharma financials

Revenue TTM $8.9 million
Gross profit TTM $349,270
Return on assets TTM -9.4%
Return on equity TTM -58.56%
Profit margin -41.2%
Book value $0.11
Market capitalisation $10.5 million

TTM: trailing 12 months

China Pharma share dividends

We're not expecting China Pharma to pay a dividend over the next 12 months.

Have China Pharma's shares ever split?

China Pharma's shares were split on a 1000:21804 basis on 14 August 2003. So if you had owned 21804 shares the day before before the split, the next day you'd have owned 1000 shares. This wouldn't directly have changed the overall worth of your China Pharma shares – just the quantity. However, indirectly, the new 2080.4% higher share price could have impacted the market appetite for China Pharma shares which in turn could have impacted China Pharma's share price.

China Pharma share price volatility

Over the last 12 months, China Pharma's shares have ranged in value from as little as $0.2 up to $0.97. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NYSE MKT average) beta is 1, while China Pharma's is 0.4737. This would suggest that China Pharma's shares are less volatile than average (for this exchange).

China Pharma overview

China Pharma Holdings, Inc. develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products primarily to hospitals and private retailers in the People's Republic of China. The company offers products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. Its products include Cerebroprotein Hydroloysate injection to treat memory decline and attention deficit; Gastrodin injection for tiredness, loss of concentration, poor sleep, and traumatic syndromes of the brain; Propylgallate and Ozagrel Sodium to treat cerebral thrombosis, coronary heart disease, and after surgery complications; Alginic Sodium Diester injection for ischemic heart, cerebrovascular, and high lipoprotein blood diseases; Bumetanide injection to treat edema diseases; and Candesartan for hypertension. It also provides Roxithromycin dispersible tablets for pharyngitis and tonsillitis; Cefaclor dispersible tablets for tympanitis, lower respiratory tract infection, urinary tract infections, and skin/skin tissue infection; Cefalexin capsules for acute tonsillitis; Andrographolide for sore throat caused by upper respiratory tract infection; Clarithromycin granules and capsules; and Naproxen Sodium and PseudophedrineHydrochlorida sustained release tablets. In addition, the company offers Hepatocyte growth-promoting factor, Tiopronin, Compound Ammonium Glycyrrhetate S, and Omeparzole for the treatment of digestive diseases. Further, it provides Vitamin B6 injection; Granisetron Hydrochloride injection to treat nausea and vomiting caused by radiotherapy and chemotherapy during the treatment of malignant tumors; Noni Enzyme, a food supplement; sanitizers; and masks.

Frequently asked questions

What percentage of China Pharma is owned by insiders or institutions?
Currently 47.873% of China Pharma shares are held by insiders and 1.483% by institutions.
How many people work for China Pharma?
Latest data suggests 236 work at China Pharma.
When does the fiscal year end for China Pharma?
China Pharma's fiscal year ends in December.
Where is China Pharma based?
China Pharma's address is: No. 17, Jinpan Road, Haikou, China, 570216
What is China Pharma's ISIN number?
China Pharma's international securities identification number is: US16941T1043
What is China Pharma's CUSIP number?
China Pharma's Committee on Uniform Securities Identification Procedures number is: 16890J107

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site